Nucleic Acid Therapeutics Initiative
  • Organisation
  • Science
  • Accelerator
    • Funding Platform
    • Funding Opportunities
    • Portfolio
  • Careers
  • News & Events

Ligand-guided siRNA Therapeutics: A Precision Delivery Approach for Retinal Disorders

Posted on March 2, 2026 by Vanessa Tay
← Evaluation of a combination siRNA Therapy for an Ocular Disease using In-Vitro Screening Platforms
Email
LinkedIn
Nucleic Acid Therapeutics Initiative (NATi)
31 Biopolis Way, Nanos #09-01, Singapore 138669
© 2026 Nucleic Acid Therapeutics Initiative | Privacy Policy | Terms and Conditions
Nucleic Acid Therapeutics Initiative
Join OurMailing List